IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives

The past decade has seen tremendous developments in novel cancer therapies through targeting immune-checkpoint molecules. However, since increasing the presentation of tumor antigens remains one of the major issues for eliciting a strong antitumor immune response, dendritic cells (DC) still hold a g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapenta, Caterina, Gabriele, Lucia, Santini, Stefano Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711454/
https://www.ncbi.nlm.nih.gov/pubmed/33086492
http://dx.doi.org/10.3390/vaccines8040617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711454/
https://www.ncbi.nlm.nih.gov/pubmed/33086492
http://dx.doi.org/10.3390/vaccines8040617

Ejemplares similares